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Background: We previously reported T cell deficits and pro-inflammatory gene activa-
tion in circulating monocytes of two cohorts of bipolar disorder (BD) patients, a cohort of 
postpartum psychosis patients and in bipolar offspring. Pro-inflammatory gene activation 
occurred in two clusters of mutually correlating genes, cluster 1 for inflammation-related 
cytokines/factors, cluster 2 for motility, chemotaxis, and metabolic factors.
aim: To verify these cellular immune abnormalities in yet another cohort [the bipolar 
stress study (BiSS) cohort] of relative old (52 years, median) BD patients and to relate 
immune abnormalities to hair cortisol levels, measured in this cohort and representing 
long-term systemic cortisol levels, and to the presence of the metabolic syndrome 
(MetS), which was prevalent in 29% of the BiSS patients.
Methods: Monocyte immune gene activation (quantitative polymerase chain reaction) 
and T cell deficits (fluorescence-activated cell sorting analysis) were determined in 97 
well-controlled, largely euthymic BiSS BD patients. Monocyte genes included the cluster 
1 and 2 genes, the genes for the glucocorticoid receptor (GR) α and GRβ, and the gene 
for hepatocyte growth factor [HGF, a marker of monocyte-derived circulating angiogenic 
cells (CACs)]. CACs serve vessel repair. Abnormal numbers are found in patients with 
MetS and vascular damage.
results: As compared to healthy controls: (1) the pro-inflammatory cluster 1 genes were 
downregulated, and the GRα and the HGF gene were upregulated in the monocytes of 
the BiSS patients and (2) T cell deficits were shown (reduced numbers of lymphocytes 
in particular of T cells). Within the reduced T cell population, a shift had taken place in 
the T-helper populations: T-helper 17 and T-helper 2 increased and T  regulatory cells 
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inTrODUcTiOn
The last 10 years evidence has accumulated that dysfunctions of 
T cells, and monocytes/macrophages are important factors in the 
development of bipolar disorder (BD). The majority of studies 
focused on cytokine levels in serum, and a recent meta-analysis 
confirmed the elevation of pro-inflammatory, anti-inflammatory, 
and regulatory cytokines in BD (1).
Cellular studies have accumulated too. Our team has studied 
in the past 10  years the percentages of circulating subsets of 
T cells and the monocyte inflammatory gene expression in three 
patient cohorts of BD patients. We have studied (1) a cohort of 
56 BD patients from the Dutch site of the Stanley Foundation 
Bipolar Network (D-SFBN) cohort, mean age 42  years (2, 3), 
(2) a cohort of 90 BD patients, aged 43 years (mean) from the 
MOODINFLAME-Groningen-Leuven site (4), and (3) a cohort 
of 140 children of a bipolar parent in follow-up, from 16 through 
29  years, the so-called Dutch bipolar offspring (DBO) study 
(5). In these studies, we detected that the monocytes of subjects 
were characterized by the abnormal expression of two coherent 
clusters of inflammation-related genes. One cluster of monocyte 
genes represented pro-inflammatory cytokines and key regulat-
ing compounds for the production of these cytokines (cluster 1 
with genes, such as IL1B, IL6, TNF, PDE4B, and ATF3). The other 
cluster represents monocyte genes playing a role in chemotaxis, 
motility, nuclear signaling, and metabolism (cluster 2 with genes, 
such as CCL2, CCL7, NAB2, PTPN7, and DHRS3). The two 
clusters were found upregulated in monocytes particularly during 
a manic/depressive episode (4, 6), in longstanding disease with an 
early onset (6), and in 16-year-old DBO subject irrespective of the 
presence of mood symptoms (5).
The pro-inflammatory state of the monocytes was also found 
in yet another cohort of patients (a fourth cohort), namely, 
patients with postpartum psychosis, using not only gene expres-
sion but also microRNA profiling (7, 8). Postpartum psychosis 
is a pathologic condition related to BD. In postpartum disorder, 
monocytes not only showed increased levels of cluster 1 and 2 
genes (7) but also decreased levels of miR-146a (8). MiR-146a 
is a well-established inflammation-regulating microRNA, and its 
decrease underscored the pro-inflammatory state of the patient 
monocytes. In addition, in silico studies showed monocyte miR-
146a to target genes of the pro-inflammatory monocyte signature, 
such as PTGS2 and IRAK2.
Indeed, microRNA studies form an entire new field to inves-
tigate a new layer of epigenetic regulation of cellular function. 
While the study of Weigelt et al. (8) and those of others (9) target 
circulating leukocytes, most studies in psychiatry have focused 
on abnormal microRNA expression in the brain investigating 
microRNAs playing a role in brain development [reviewed in 
Ref. (10)].
Apart from the pro-inflammatory state of monocytes, we also 
detected in these four cohort studies that the T cell system was 
set at another equilibrium. In all cohorts, there was a deficit in 
the number of T cells, while within the T cell population there 
were abnormal fluctuations over time in the circulating levels of 
anti-inflammatory T regulatory (Treg) cells and T-helper 2 (Th2) 
cells and of pro-inflammatory T-helper 1 (Th1) and T-helper 17 
(Th17) cells (7, 11, 12).
These observations enforced our idea that the immune system 
of individuals at high risk to develop BD (the DBO subjects) and 
of BD patients was abnormal and dynamically activated and deac-
tivated over time showing episodes of inflammatory activation, 
particularly in early stages of the disease process in adolescence 
and the absence of mood symptoms and during active disease.
Recently, we collected circulating leukocytes of another cohort 
of BD patients. These patients belonged to the so-called Bipolar 
Stress Study (BiSS) cohort and had a mean age of 52 years (signifi-
cantly older than the Stanley Foundation, the MOODINFLAME, 
and the DBO cohort). The BiSS study is a 2-year longitudinal 
study, designed to identify risk factors that have an impact on 
the clinical course and the treatment of outpatients with BD (13). 
The cohort has been studied in depth clinically (14–17) and is 
special in that the subjects had also been studied for the presence 
of the metabolic syndrome (MetS) (18). BiSS subjects showed 
a significantly higher prevalence of MetS when compared to 
subjects with MDD and non-psychiatric controls of the same age 
(28.4 versus 20.2 and 16.5%, respectively, p < 0.001), also when 
adjusted for sociodemographic and lifestyle factors. It is known 
that patients with severe mental illness do have a higher risk for 
cardiovascular disease (19).
Also special is that BiSS subjects had been studied for their 
hypothalamic–pituitary–adrenal (HPA) axis activity over a 
longer period of time via measuring their hair cortisol level (16). 
The hair cortisol test is relatively novel and reflects the mean 
HPA-axis activity over a period of time, in our case over the last 
3 months before the leukocyte collection. Staufenbiel et al. (17) 
decreased. Correlations between hair cortisol, the MetS, monocyte gene activation, and 
T cell deficits were not found.
conclusion: T cell deficits most likely are a trait phenomenon of BD, since they have also 
been found in the other cohorts of BD patients and in bipolar offspring. Monocytes of this 
cohort showed an anti-inflammatory set point, suggesting that pro- and anti-inflamma-
tion are state characteristics of BD. The monocyte gene profile indicated an increased 
CAC activity; the question arises whether this is due to putative vessel damage in these 
relatively old patients with a high prevalence of the MetS.
Keywords: bipolar disorder, T cell deficits, angiogenic cells, gene expression, hypothalamic–pituitary–adrenal axis
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reported an increase of hair cortisol levels in the BD patients of 
the BiSS cohort, but only in those with negative life events within 
3  months before the cortisol determination. Hair cortisol was 
found normal across the entire BiSS cohort.
The MetS, the HPA axis, and the immune system have strong 
mutual influences (20–22). The collection of circulating leuko-
cytes in the BiSS cohort at the end of the 2-year follow-up period 
enabled us to study the monocyte gene expression and T  cell 
subset distribution in the BiSS subjects in relation to the mean 
HPA-axis activity in the 3-month period before blood collection 
and in relation to the presence/absence of the MetS.
We therefore not only determined the earlier reported cluster 
1 and 2 gene sets in the monocytes of the BiSS subject but also 
the gene expression levels of the genes for the glucocorticoid 
receptor α (GRα, activating) and GRβ (blocking receptor). We 
hypothesized that there would a relationship between the expres-
sion of the GR receptor in monocytes, the cluster 1 and 2 gene 
expression, and the hair cortisol levels.
Not only did we add the genes for the GR but also additionally 
determined the expression of the gene for hepatocyte growth 
factor (HGF). In a recent study on type 2 diabetic (T2D) and 
MetS patients (23), we found HGF gene expression raised in the 
circulating monocytes of the T2D patients. HGF is an important 
vascular repair factor (24) and monocyte-derived circulating 
angiogenic cells (CACs), capable of repairing endothelial dam-
age, are characterized by the expression of HGF (25). We hypoth-
esized that the HGF expression would be raised in particularly 
BiSS subjects with the MetS.
In addition to monocyte gene expression studies, fluorescence-
activated cell sorting (FACS) analysis was performed on the col-
lected leukocytes of the BiSS cohort to determine the percentages 
of monocytes, lymphocytes, B cells, NK cells, T cells, as well as 
the distribution of the T cells into the cytotoxic T cells and the 
helper T  cells. The latter population was further quantified for 
its subpopulations, i.e., the regulatory T cells, the Th1 cells, the 
Th2 cells, and the Th17  cells. We hypothesized that we would 
detect again the T cell deficits and an abnormal distribution of 
T-helper subsets within the circulating T cell population of the 
BiSS subjects, similar as was found before.
Thus, our prime objective of this study was to determine the 
monocyte gene activation patterns and leukocyte distribution 
abnormalities in this new BiSS cohort of BD patients, and to 
compare outcomes to the outcomes of the previous studied BD 
cohorts, which had been investigated with the same techniques. 
Our secondary objective was to study correlations between the 
immune outcomes and the hair cortisol level and the presence/
absence of the MetS.
MaTerials anD MeThODs
Patients
The study design and patient population have been described 
elsewhere in detail (13–15, 17). For this study, only patients 
with hair cortisol measurements were selected. The study 
was conducted as part of the MOODINFLAME (EU-FP7-
HEALTH-F2-2008-222963) and the PSYCHAID project (EU- 
FP7-PEOPLE-2009-IAPP-MarieCurie-286334) on the samples 
cross-sectional collected at the end of the 2-year follow-up 
study. The study protocol was approved by the Medical Ethics 
Committee of the Clinic for Mood disorders, Parnassia Group 
(presently PsyQ), The Hague, The Netherlands, and all patients 
gave informed consent after a full description of the study.
To summarize, adult patients (n = 97) with BD I, II, and not 
otherwise specified were included. As this was a naturalistic study 
design, we included all outpatients with BD. Diagnosis of BD and 
psychiatric comorbidities were based on DSM-IV criteria and were 
assessed with the MINI International Neuropsychiatric Interview 
Plus (26). Sociodemographic data and disease-related data were 
collected in interviews by trained psychologists. Disease-related 
data included disease characteristics (age of onset, disease dura-
tion, mood classification, comorbidities including the MetS) and 
medication use (lithium, antipsychotics, anti-depressives, and 
benzodiazepines). Mood classification was administrated with 
the self-rated Quick Inventory of Depressive Symptomatology 
and the observer based Young Mania Rating Scale (27, 28). MetS 
was defined according to the National Cholesterol Education 
program—Adult Treatment panel III (29).
Exclusion criteria were age below 18 years and the diagnosis 
schizoaffective disorder. As the BiSS study was a naturalistic 
study, we included all patients with BD and only noted comor-
bidities, such as thyroid disease, diabetes, and endocrine disease 
in general. Patients with glucocorticoid usage in the last 6 months 
or without sufficient hair growth at the posterior vertex were also 
excluded (this was interfering with the hair cortisol determina-
tion). Methods and detailed data on the hair cortisol levels and 
GR polymorphisms are available in previous studies on this 
cohort (15–17). The reference upper limit of the normal hair 
cortisol level was defined by Manenschijn et al. (30) as 52 pg/mg 
hair in healthy non-obese individuals. The reference lower limit 
has not yet been determined.
healthy controls (hcs)
The HC group was established by combining HCs of the studies in 
the MOODINFLAME and PSYCHAID consortia (Departments 
of Psychiatry, University Hospitals of Rotterdam, Groningen, 
Münster, Leuven, and München). These HCs had been selected 
at the same time as the patients, and material was processed in the 
same way by the same technicians together with the materials of 
the patients. Exclusion criteria for HC in the MOODINFLAME 
and PSYCHAID studies were psychiatric and immune disease 
or endocrine disease in both the subject and first-degree family 
members and medication use (apart from oral contraceptives). 
Of a total number of 519 HC with peripheral blood mononuclear 
cell (PBMC) data available, only HC with complete information 
on gender, age, and BMI was included for comparison (n = 272). 
From these 272 controls, we selected 47 controls for the monocyte 
gene expression evaluation, since these controls had been tested 
in the same assays as the BD cases (to avoid inter-assay variation). 
For the leukocyte subset determination, we finally selected 72 
controls matched for age and gender (see Results).
Blood collection and Preparation
Blood was drawn using sodium heparin tubes for immune 
cell preparation, and the heparinized blood was subsequently 
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centrifuged to prepare PBMC suspensions as described previously 
in detail (7, 31). PBMCs were frozen in 10% dimethyl sulfoxide 
and stored in liquid nitrogen.
Determination of Monocyte gene 
expression
CD14+ monocytes were isolated from the frozen PBMCs using a 
magnetic cell sorting system (Miltenyi Biotec, Germany) result-
ing in a purity of monocytes >95%. RNA was isolated from the 
purified monocytes, and 1 μg of RNA was reverse transcribed 
using the cDNA high-capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Carlsbad, CA, USA). The cDNA was used 
in quantitative polymerase chain reaction (qPCR) to determine 
gene expression using the comparative threshold (CT) cycle 
method (32). qPCR was performed using a TaqMan Universal 
PCR mastermix and TaqMan probes (Applied Biosystems). 
Gene expression was normalized to expression of housekeeping 
gene ABL1, and the resulting ΔCT values were used for further 
analyses.
Genes of interest were selected based on previous findings of 
abnormally expressed genes in patients with BD (4, 5, 11), MDD 
(31), type 2 diabetes (23), and systemic autoimmune diseases 
[the IFN-induced inflammatory genes (33)], and known to be 
involved in major inflammatory or immune activation pathways 
in monocytes and macrophages. We selected the most consist-
ently over expressed genes. A list of included genes is given in 
Table S1 in Supplementary Material.
Monocyte gene expression analysis
It has been published extensively before that the determined 
genes are expressed in three mutually coherent clusters, i.e., 
cluster 1, cluster 2, and the IFN cluster (7, 11, 23, 31, 33). For 
this study, principle component analysis was used to determine 
which genes could be allocated to these clusters. Furthermore, the 
analysis showed the order of correlation of each gene in the found 
clusters, enabling the use of a limited set of the highest correlating 
genes (key genes) for further comparisons. ΔΔCT values (ΔCT 
values of patients relative to the mean ΔCT value of controls 
within the same assay) were used to compare gene expression of 
BD patients with HC for the key genes of each cluster. The results 
were expressed as fold change (FC) relative to HC. The researcher 
was blind to the identity of the sample during the FACS measure-
ment and analysis of the data.
Determination of the Percentage and 
subset Distribution of circulating 
leukocytes
Lymphocytes, monocytes (CD14+), B  cells (CD19+), NK  cells 
(CD56+), total T cells (CD3+), T-helper cells (CD4+), cytotoxic 
T  cells (CD8+), and regulatory T  cells (CD25+FoxP3+) were 
determined using FACS and described as percentage relative to 
total mononuclear cells. Furthermore, Th1 (IFN-γ+), Th2 (IL4+), 
and Th17 (IL17A+) subsets were assessed and described relative 
to the total number of leukocytes. All used procedures including 
the gating strategy are extensively described in Snijders et al. (12). 
The researcher was blind to the identity of the sample during the 
FACS measurement and analysis of the data.
statistics
Statistical analysis was performed using SPSS software, version 
23.0 (IBM Corp, Armonk, NY, USA). Normally distributed con-
tinuous variables were expressed as mean with 95% confidence 
intervals and compared using two-sided T-tests. Log transforma-
tion was applied on Th1, Th2, and Th17 cells and hair cortisol 
levels to achieve normality. Non-normal data, mainly the various 
clinical variables, were described with median (range) and com-
pared with Mann–Whitney U tests.
Principle component analysis was used on the 36 genes 
(excluding HGF and both GR isotypes) with oblique rotation 
(direct oblimin). The Kaiser–Meyer–Olkin measure verified the 
sampling adequacy, KMO = 0.89. An initial analysis was run to 
determine the number of factors to be extracted. A combination 
of three factors with the highest eigenvalue and clear inflections 
shown in the scree plot explained 63.31% of the variance. The 
maximum number of convergence was 25.
For monocyte gene expression one-sample T-test was 
performed on normally distributed ΔΔCT values, and data are 
presented as FC of the patient gene expression relative to the HC 
value set to 1 for each given gene.
resUlTs
clinical characteristics of the Patients, 
including the Prevalence of the Mets and 
hair cortisol
The large majority of the BD patients were BD I cases (76%), 
had longstanding disease (mean duration 23  years), were on 
lithium (76%), were well-controlled with low self-rated QIDS 
scores (median 5), and showed a high prevalence of the MetS 
(29%). Further detailed characteristics of BD patients are given 
in Table 1.
Hair cortisol levels of the BiSS cohort have been published in 
detail before (16, 17). Using the cut-off determined by Staufenbiel 
et  al. (17), the large majority of BD patients showed normal 
hair cortisol levels (n = 84, median = 25.6, range = 10.6–51.9), 
the remaining patients had elevated cortisol levels (n  =  13, 
median = 77.2, range = 56.7–370.8).
Monocyte gene expression
A total of 39 genes were included in qPCR, shown with descrip-
tion in Table S1 in Supplementary Material. Monocyte gene 
expression could successfully be determined in 97 BD patients. 
Monocyte gene expression of patients was compared to monocyte 
gene expression of 47 HC of whom blood was tested in the same 
assays (to avoid inter-assay variation for monocyte gene expres-
sion). Of these 47 healthy subject data on gender, age and BMI 
were available: median age was 48 years (range 24–72), percent-
age females 57, and a mean BMI of 25.6 (SD 3.6). BMI and gender 
were not statistically significantly different between patients and 
HC. The age of the HC (48 years, mean) was statistically different 
from the age of the patients (52 years, mean, p < 0.01). However, 
age was not found to correlate to monocyte gene expression (data 
not shown). Nevertheless, and to be sure, corrections were carried 
out in statistics for age, gender, and BMI.
TaBle 2 | Monocytes in bipolar disorder patients compared to healthy 
control (hc).
Fca 95% ci p Value
cluster 1
IL1B 0.72 0.59–0.89 0.002
CCL20 0.58 0.43–0.78 0.001
IL6 0.76 0.61–0.96 0.021
cluster 2
NAB2 0.80 0.67–0.96 0.017
CCL7 0.93 0.65–1.32 0.669
CCL2 1.05 0.82–1.34 0.703
interferon-related cluster
IFI44 1.01 0.90–1.13 0.860
IFIT3 1.04 0.90–1.19 0.631
Glucocorticoid receptor (GR) α 1.03 1.00–1.07 0.042
GRβ 0.97 0.87–1.09 0.626
Hepatocyte growth factor 1.10 1.03–1.18 0.005
aFold change (FC) relative to HC.
The most important genes for each respective cluster are shown as found by principle 
component analysis (Table S2 in Supplementary Material).
A full list of compared genes is included in Table S3 in Supplementary Material.
Values marked in bold indicate numbers that are significant on the 95% confidence limit.
TaBle 1 | characteristics of bipolar patients and healthy controls.
all bipolar disorder patients 
(n = 97)
age (median, range), years 52 (20–83)
Female (n, %) 61 (63)
BMi (mean, SD) 26.2 (4.5)
DsM-iV classification (n, %)
Bipolar I 74 (76)
Bipolar II 22 (23)
Non-specified 1 (1)
QiDs score (median, range) 5 (0–22)
Mood classification (n, %)
Euthymica 50 (52)
Mild depressionb 23 (24)
Moderate depressionc 14 (14)
Severe depressiond 5 (5)
Very severe depressione 1 (1)
Manicf 0
Not determined 4
age of onset (median, range), years 21.5 (20–59)
Disease duration (median, range), years 23 (0–61)
Metabolic syndrome (n, %) 28 (29)
endocrine disease (n, %) 10 (10)
Thyroid diseaseg 7 (7)
Diabetes mellitus type 2 3 (3)
smoking (n, %) 32 (33)
Medication (n, %)
Lithium 74 (76)
Antipsychotics 25 (26)
Antidepressants 30 (31)
Benzodiazepines 29 (30)
aSelf-rated Quick Inventory of Depressive Symptomatology (QIDS-SR) score ≤5, YMRS 
<13.
bQIDS-SR score 6–10.
cQIDS-SR score ≥11.
dQIDS-SR score ≥16.
eQIDS-SR score ≥21.
fYoung Mania Rating Scale score ≥13.
gStable disease (normal TSH + fT4).
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The results of the principle component analysis are shown 
in Table S2 in Supplementary Material. As expected the three 
distinct clusters could be found as in previous studies (7, 11, 23, 
31, 33). The first cluster was by and large corresponding to the 
previously described cluster 1 (pro-inflammatory genes) and the 
second by and large to the previously described cluster 2 (genes 
involved in chemotaxis, cell adhesion nuclear signaling, and 
motility) using the previous cohorts of BD patients. The principle 
component analysis also showed a third cluster, i.e., a cluster of 
interferon-induced genes, on which we have extensively pub-
lished in systemic autoimmune diseases, such as Sjögren disease, 
SLE, and systemic sclerosis (33). In these latter diseases, this gene 
set is over expressed in monocytes due to high levels of type II 
IFNs in the circulation.
Some of the lower ranking genes of cluster 1 (like HSPA1A/B) 
and of cluster 2 (like CD9) in the previous studies did not 
belong to the present clusters in this study anymore (Table S2 
in Supplementary Material). Since there is not an exact overlap 
between the clusters in the various studies, we only took the three 
top genes of the principle component analysis into consideration 
for further analysis and calculations. These top genes belong in 
each of the previous study also to the most discriminative genes 
for the cluster.
The fold expression of the top three genes per cluster as found 
with principle component analysis is shown relative to HCs in 
Table 2 (the outcomes of the entire list of measured genes can be 
found in Table S3 in Supplementary Material). Gene cluster 1, as 
measured by the top key genes IL1B, CCL20, and IL6, was signifi-
cantly downregulated in BD patients, Table S3 in Supplementary 
Material shows that indeed the vast majority of cluster 1 genes (13 
out of 15) is significantly downregulated. We take this observa-
tion as indicating that the monocytes of the BiSS BD patients are 
set at an anti-inflammatory set point.
Of the cluster 2 key genes, only the top key gene NAB2 showed 
a significantly reduced expression as compared to the expres-
sion level in the monocytes of HCs; Table S3 in Supplementary 
Material shows that indeed only a minority of cluster 2 genes was 
significantly downregulated (5 of 15 genes).
The IFN genes were normally expressed in the monocytes of 
the BD patients.
The expression of the GRα and HGF gene was significantly 
upregulated in the monocytes of BD patients as compared to 
those of HC (p = 0.039 and p = 0.004, respectively) (Table 2).
Table 3 shows that the expression level of HGF in monocytes 
correlated significantly positive with the expression of the activat-
ing GRα and with the IFN cluster, but negative with the expression 
levels of the cluster 1 and 2 genes: the higher the HGF expression 
the higher the GRα expression and the IFN expression, but the 
lower the expression of IL1, CCL20 and IL6, and NAB2, CCL2, 
and CCL7.
Table 3 also shows that the gene expression of the blocking 
GRβ expression in the monocytes of the patients correlated 
positive to the cluster 1 gene expression, an observation reported 
before (7, 31).
TaBle 3 | correlations of hair cortisol, glucocorticoid receptor (gr) α and grβ receptor gene expression, hepatocyte growth factor (hgF) gene 
expression, and cluster 1-, 2- and interferon-related cluster scores.
hgF hair cortisol grα il1B ccl20 il6 ccl7 naB2 ccl2 grβ iFi44 iFiT3
HGF 0.21 0.34 −0.42 −0.38 −0.50 −0.43 −0.53 −0.35 −0.18 0.18 0.41
Hair cortisol 0.21 0.12 −0.12 −0.06 −0.05 0.00 −0.14 −0.02 0.13 0.14 0.19
GRα 0.34 0.12 −0.39 −0.24 −0.30 −0.10 −0.20 −0.15 −0.04 0.12 0.25
GRβ −0.18 0.13 −0.04 0.35 0.38 0.40 0.34 0.38 0.33 0.11 −0.07
Correlations significant at the p = 0.05 level are colored.
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The disease characteristics as given in Table 1, including the 
mood state, the medication, and the presence of the MetS, did not 
correlate to the various gene expression levels in the monocytes 
of the BD patients (data not shown).
In the correlations between hair cortisol and other parameters, 
we used an analogous approach. The hair cortisol levels did not 
significantly correlate to any of the above described immune 
parameters (Table 3). We did, however, confirm the correlation of 
the hair cortisol with negative life events in the previous months 
to bloodletting as reported earlier by Staufenbiel et al. (17).
leukocyte subset Determinations
For leukocyte subset determination, inter-assay differences per-
formed on PBMC in the various cohorts of MOODINFLAME 
and PSYCHAID and obtained at different sites and collection 
times appeared to be negligible, therefore a total number of 
519 HC with PBMC data were available for evaluation against 
the BiSS cases; however, only HC with complete information on 
gender, age, and BMI (n = 272) were included for comparison 
with the BiSS cases. Out of these 272 HC, a selection was made 
to match for age (maximum 3-year difference), gender, and BMI 
(maximum three BMI points difference) with the BiSS patient 
group; this resulted in 72 pairs (BD cases–HC pair) for leukocyte 
subset determination. The mean age of these pairs was 52 years 
(range 20–67), percentage females 63, and mean BMI 25.3 (SD 
3.2) not statistically different from the entire group of BiSS BD 
patients (Table 1).
Table 4 shows that there was a reduction of the percentage of 
lymphocytes in the BD patients. The percentage of monocytes 
was raised. Since many of the patients were on lithium, we car-
ried out a separate comparison between lithium-treated and 
non-lithium-treated BD patients. This comparison did not show 
an effect of lithium treatment (see Table 4). Correlations with the 
usage of other drugs were also not found (data not shown).
With regard to the subpopulations of lymphocytes, Table  4 
shows that it was particularly the CD3+ (pan) T  cells, which 
were decreased and within this population both the CD3+CD8+ 
cytotoxic T cells and the CD3+CD4+ T-helper cells. Within the 
population of CD3+CD4+ T-helper cells a shift had taken place, 
there was a significant increase in both the percentages of Th2 and 
Th17 cells, while the Treg cells had decreased. These abnormalities 
were also present in patients not on lithium, except for the Th2 
increase; this was only seen in the lithium treated BD patients.
B cell, NK cell, and Th1 cell levels in the BD patients were not 
different from the HCs.
In the correlations between hair cortisol and the leukocyte 
subsets, we again used an analogous approach. Correlations 
between hair cortisol and any of the leukocyte subsets could not 
be detected. This also applied for correlations between the leuko-
cyte subsets and clinical characteristics of the patients, including 
the mood state and the presence of the MetS (data not shown).
DiscUssiOn
This study shows that the pro-inflammatory gene cluster 1 expres-
sion was downregulated in the monocytes of the BD patients of 
the here studied BiSS cohort, indicating a reduced inflammatory 
state of the circulating monocytes as compared to that of HCs.
This reduced inflammatory state of the circulating monocytes 
of the BiSS patients is in contrast to the pro-inflammatory state 
observed in previously studied cohorts of BD patients while in 
all cohorts the same collection and laboratory determination 
techniques were used. In the BD patients of the D-SFBN cohort, 
an increased inflammatory gene expression was found that cor-
related to the activity of disease, particularly to manic symptoms 
(2, 3, 6). The patients in the D-SFBN cohort were indeed special 
in that a relative high percentage had active severe disease (38%). 
In the MOODINFLAME Leuven–Groningen cohort, the raised 
pro-inflammatory gene expression in monocytes was again only 
found in patients with active mania or depression, these patients 
constituted around 10% of the cohort (4). Our data thus support a 
concept that in BD patients over expression of monocyte inflam-
matory genes can only be found during active episodes of the 
disease, in particular during mania. The BiSS cohort only had six 
patients with severe depression.
Our observations on monocytes are by and large in accord 
with serum cytokine/inflammatory factor studies that also found 
that BD patients with an active episode and particularly those 
who have or develop manic symptoms have an increased inflam-
matory activity, especially high CRP, compared with individuals 
who do not develop manic symptoms (34).
However, before to conclude that the pro-inflammatory state 
in BD is only linked to (manic) mood derailment in BD, it is 
relevant that in the studies on the DBO children over expression 
of monocyte inflammatory genes was also found in adolescents 
at 16 years of age, but in this case irrespective of present or later 
mood symptoms (5). Five years later, in early adulthood (at 
21  years of age), the pattern of monocyte gene expression had 
changed in the DBO children to a reduced expression of cluster 1 
genes, but still increased cluster 2 gene upregulation. At 28 years, 
TaBle 4 | Peripheral blood mononuclear cells (PBMcs) in bipolar disorder (BD) patients compared to matched healthy controls (hcs).
all hc 
(n = 72)
all BD 
patients 
(n = 72)
hc no 
lithiumb 
(n = 16)
BD no lithium 
(n = 16)
hc lithiumd 
(n = 56)
BD lithium 
(n = 56)
Mean sD Mean sD pa Mean sD Mean sD pc Mean sD Mean sD p
Lymphocytes 76.85 0.88 72.54 0.94 <0.001 79.81 1.33 76.28 1.72 0.088 76.00 1.06 71.47 1.08 0.003
CD19+ B cells 7.32 0.28 7.56 0.30 0.56 6.65 0.50 7.38 0.60 0.32 7.52 0.32 7.61 0.36 0.84
CD56+ NK cells 9.11 0.58 10.21 0.64 0.19 10.75 1.30 10.64 1.59 0.95 8.62 0.65 10.10 0.71 0.12
CD14+ monocytes 17.63 0.74 21.01 0.70 0.001 14.23 1.19 18.62 1.54 0.020 18.54 0.85 21.72 0.80 0.007
CD3+ T cells 57.66 0.99 53.31 1.17 0.005 59.98 1.80 56.53 2.67 0.25 56.99 1.19 52.38 1.32 0.009
CD3+CD8+ cytotoxic T cells 16.31 0.69 14.65 0.67 0.083 18.50 1.72 16.16 1.81 0.32 15.68 0.76 14.22 0.72 0.11
CD3+CD4+ T-helper cells 38.42 0.90 36.18 1.11 0.11 38.74 2.33 37.53 2.37 0.69 38.33 0.98 35.79 1.29 0.15
CD3+CD4+CD25hiFoxP3+ Treg 1.56 0.07 1.46 0.05 0.21 1.51 0.18 1.60 0.13 0.65 1.58 0.07 1.41 0.06 0.076
CD3+CD4+IFN-γ+ T-helper 1 cells 4.36 0.26 4.43 0.29 0.73 4.78 0.61 5.27 0.89 0.80 4.23 0.29 4.19 0.29 0.80
CD3+CD4+IL4+ T-helper 2 cells 0.43 0.03 0.53 0.04 0.037 0.53 0.10 0.41 0.07 0.26 0.40 0.03 0.56 0.04 0.002
CD3+CD4+IL17A+ T-helper 17 cells 0.25 0.02 0.33 0.03 0.003 0.25 0.03 0.30 0.03 0.18 0.25 0.02 0.34 0.04 0.009
Percentages of indicated subpopulations are given per PBMC (mononuclear white cells). The p values in comparison of the lithium and not-lithium using BD patients versus their 
respective controls are given below.
Values marked in bold indicate numbers that are significant on the 95% confidence limit.
pa: all BD patients versus all matched HCs.
HC no lithiumb: matched HCs corresponding to BD patients with no lithium usage.
pc: BD patients without lithium usage versus corresponding matched HC.
HC lithiumd: matched HCs corresponding to BD patients with lithium usage.
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monocyte gene expression had virtually normalized. Neither 
increases nor decreases in monocyte inflammatory gene expres-
sion were linked to mood symptomatology in the DBO children 
in the various stages of investigation.
Collectively, these findings on the inflammatory state of 
monocytes point in the direction of dynamic changes of inflam-
matory gene expression in monocytes over time in subjects at risk 
to develop BD and in BD patients. Apparently the inflammatory 
set point of monocytes is dependent on the (environmental or 
hormonal) state of the organism, an observation that is supported 
by twin studies in BD, showing that common endogenous or 
environmental factors play a prime role in the pro-inflammatory 
set point of the monocytes (35). In sum, only episodes of pro-
inflammatory activation occur in circulating monocytes of 
individuals at risk to develop BD and in BD patients, and these 
episodes are probably environmentally and endogenously pre-
cipitated and only in part linked to the presence and activity of 
(manic) mood symptoms.
The present study also shows that the gene expression of the 
vascular repair factor HGF was significantly raised in the mono-
cytes of BD patients of the BiSS cohort as compared to HCs. We 
previously found a similar gene expression profile, i.e., a reduced 
pro-inflammatory cluster 1 and raised HGF expression, in the 
circulating monocytes of 64 T2D patients (23, 36). These T2D 
patients were on average 62 years old.
We took the observation in the studies of Baldóon Rojas et al. 
of a high HGF expression and a low expression of inflammatory 
signs in the circulating monocytes of T2D patients as indicating 
that many of the circulating monocytes in the T2D cases were dif-
ferentiating into CACs and involved in the repair of endothelium 
damaged by the diabetic process. CACs are bone marrow-derived 
monocytes involved in vascular regeneration and angiogenesis, 
are anti-inflammatory, and exert their repair function by secret-
ing vascular growth factors, such as HGF, which is considered as a 
marker of CACs (25). Healthy angiogenesis is crucial for vascular 
regeneration (24).
We therefore like to hypothesize that the elevated gene expres-
sion of HGF in the anti-inflammatory monocytes of the patients 
of the BiSS cohort probably reflects that a high percentage of 
the monocytes had developed into vessel-repair-supporting 
CACs to counteract a putative endothelial damage in the BD 
patients of the BiSS cohort. Indeed, the MetS and dyslipidemia 
were prevalent in the BD patients of the BiSS cohort (18), yet 
there were no correlations between the HGF expression and the 
MetS. Therefore, formal studies in older BD patients focusing on 
monocyte-derived CAC development in relation to parameters 
of vascular damage need to be performed to verify or refute the 
here proposed idea of the development of anti-inflammatory 
CACs as overruling mechanism preventing a pro-inflammatory 
state of monocytes in BD patients. Also endothelial damage in 
atherosclerosis is considered a pro-inflammatory environment 
(37), and it is therefore at first sight puzzling that the CACs 
are anti-inflammatory. However, there is literature that it is 
particularly in  situations of chronic mild hyperglycemia (38) 
and in  situations of unstable plaque formation (39) that CACs 
and circulating monocytes become pro-inflammatory and dys-
functional. Therefore, special care should be taken in follow-up 
studies whether such conditions exist in bipolar patients next to 
a putative heightened endothelial damage.
The GRα was also higher expressed in the monocytes of the 
BD patients of the BiSS cohort as compared to those of HCs, and 
the expression of the GRα expression correlated to the expression 
of HGF. Since the GRα is the activating receptor signaling down-
regulation of pro-inflammatory molecules during glucocorticoid 
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exposure, an upregulation of the GRα suggests a higher sensitivity 
for glucocorticoids to downregulate the inflammatory state of 
monocytes.
These data suggest that in principle a raised cortisol level 
might be instrumental in downregulating the inflammatory 
state of the circulating monocytes in BD patients. Such a raised 
cortisol level was reported in BiSS BD patients who experienced 
recent negative life events (17). However, although we were able 
to verify the previous correlation between high hair cortisol levels 
and negative life events, we were unable to find in this study a 
correlation between both high hair cortisol levels/negative life 
events on the one hand and a reduced inflammatory state of the 
circulating monocytes of the BiSS cohort on the other hand.
We therefore assume that not negative life events and a higher 
HPA-axis activity, but the earlier mentioned putative endothelial 
damage and consequent transition of the circulating monocytes 
into anti-inflammatory vessel repair cells CACs plays a overrul-
ing and prime role in the here found characteristic profile (high 
HGF, reduced pro-inflammatory compounds) of the circulating 
monocytes in the BD patients of the BiSS cohort. But as stated 
before, this needs formal verification, also with regard to an 
enhanced monocyte sensitivity to dexamethasone in functional 
in vitro exposure tests.
With regard to the T cell findings in the BiSS cohort the fol-
lowing remarks. Snijders et al. (12) took the monocyte data on 
the DBO adolescents of Mesman et al. (5) further and showed 
that the DBO 16-year-old adolescents had deficits in the number 
of circulating lymphocytes, particularly of total CD3+ T  cells 
and within this population particularly in the Treg cell subset. 
Interestingly, she found that the lower the level of the anti-
inflammatory Treg cells in the DBO adolescents, the higher the 
monocyte inflammatory gene activation. These data corroborate 
earlier findings that Treg cells are capable of downregulating 
monocyte inflammatory activation and that in particular a 
defective Treg cell system might form the underlying condition 
allowing endogenous or environmental factors to induce an early 
raised pro-inflammatory state of monocytes in the 16-year-old 
DBO subjects at risk to develop BD.
During further aging of the DBO children, the aberrant T cell 
state showed a dynamic course over time. During young adult-
hood (mean age 21 years), the partial T cell deficit, i.e., the reduc-
tion in the total number of CD3+ T cell was still detectable, but 
not of the Treg cell subset anymore, but of the pro-inflammatory 
Th1 and Th17  cell subsets, suggesting a phase of relative anti-
inflammation at young adulthood, but in the presence of deficits 
of total T cells. Also the upregulation of cluster 1 inflammatory 
genes in monocytes had disappeared and even a downregulation 
of such genes as compared to HC monocytes was found (see 
before), enforcing the idea that young adulthood at 21 years of 
age was a phase of relative anti-inflammation.
In late adulthood (mean age 28 years), the various subsets of 
T cells (Th1, Th2, Th17, and Treg cells) and the abnormal mono-
cyte gene expression had largely normalized as compared to the 
controls, only the deficit of lymphocytes and total CD3+ T cells 
could still be detected.
Collectively, these DBO data show that T  cell deficits 
deregulate the inflammatory response in adolescence and young 
adulthood in individuals at risk for BD, and we assume that the 
immune disequilibria represent vulnerability factors for later BD 
development by influencing morphological brain and hippocam-
pus development during adolescence and early adulthood, since 
T  cells and non-inflammatory microglia are essential support 
cells for proper brain development (see Figure 1).
Although the T cell and monocyte inflammatory disequilibria 
were more or less normalized in adulthood in the DBO subjects, 
a partial T  cell defect (a deficit in lymphocyte and total T  cell 
numbers) still existed. This report on the BiSS BD patients with a 
mean age of 52 years still finds the apparently over time consistent 
partial T  cell deficit in showing reduced levels of lymphocytes 
and total CD3+ T cells also in the relatively old BiSS cohort, while 
the restoration within the CD4+ T-helper cells subset had further 
continued into an overshoot, showing significantly raised levels 
of Th2 and Th17 subpopulations, while Treg cells were reduced.
A composite of the dynamics over time of T cells and mono-
cytes as found in the various cohorts studied by us is shown in 
Figure 1. In this figure, it is also hypothesized that particularly 
in adolescence and early adulthood changes in brain structure 
and physiology are induced by the T cell deficits and inflamma-
tory influences. In later phases of life, partial corrections of the 
immune aberrancies occur, and only during an active episode 
signs of a peripheral monocyte inflammatory state can be found.
limitations of This study
Data on the leukocyte subpopulations could only be given as 
percentages of the total number of leukocytes or lymphocytes. 
Absolute counts of the same leukocyte populations were not per-
formed. Future studies should focus on more exact and extensive 
measurements of the actual circulating numbers of discriminat-
ing leukocyte populations.
Vasculature related factors have not been measured in the 
BiSS cohort, such as endothelin and the carotid intima thickness, 
which would have given a better impression of the state of the 
endothelium. Future studies should involve patients with a better 
metabolic characterization and characterization of the state of 
their vasculature.
Another limitation is that the exclusion criteria for patients 
and controls were not exactly the same. Patients of the BiSS 
cohort were not excluded if known with an endocrine or immune 
disease. However, endocrine diseases were recorded in the BiSS 
group (seven patients had thyroid disease and three diabetes), and 
of note the presence of endocrine disease did not correlate with 
immune outcomes (data not shown). Yet future studies should try 
and match as much as possible for the various conditions having 
an effect on the immune state of both patients and controls (age, 
gender, BMI, comorbidities, smoking, stress, etc.).
cOnclUsiOn
Despite the limitations, we are confident that this study shows that 
lymphopenia, and in particular a reduced percentage of T cells, is 
a characteristic of relatively old BD patients. Since lymphopenia 
and a reduced percentage of T cells are phenomena also found 
in children at risk for BD and younger BD patients, a deficit of 
T cells might be a trait phenomenon of BD.
FigUre 1 | a hypothetical cartoon on the natural history of the lymphocyte and monocyte changes in bipolar subjects over time and their 
consequences for brain function and support function of blood vessels. In the cartoon, it is assumed that in healthy conditions both T cells and monocytes/
microglia are essential for proper brain development and function. When there is a deficit in T cells or changing inflammatory states as in bipolar disorder (BD) and 
the pre-stages of BD, we assume that brain development and function are abnormal leading to a vulnerability for mood derailment.
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The monocyte gene expression profile of the relatively old BD 
patients showed a downregulation of inflammatory genes and 
an upregulation of HGF, suggesting CAC activity of the cells. 
This profile is different from the pro-inflammatory profile found 
in 16-year-old offspring of a bipolar parent and in BD patients 
with active disease. Therefore, the changes in monocyte profiles 
suggest dynamic changes over time in the inflammatory state of 
monocytes of individuals at risk for manic-depressive episodes. 
We therefore assume that the monocyte inflammatory set point 
is a state rather that a trait phenomenon of BD.
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